Physician profile
Daniel D Viner
NPI 1932179876
$2,281.50
in general payments reported to CMS, 2019-2025
17 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $130 · 2021: $358 · 2022: $576 · 2023: $369 · 2024: $198 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $564.39 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $458.05 | 2020-2025 | Dupixent |
| Stryker Corporation | $307.07 | 2019-2022 | |
| Alk-Abello, INC | $168.33 | 2021-2022 | |
| Glaxosmithkline, LLC. | $140.00 | 2022-2025 | Nucala |
| Integra Lifesciences Corporation | $133.85 | 2023-2025 | Microfrance, Integra, Integra Duo |
| Intersect Ent, INC. | $114.82 | 2019-2021 | |
| Optinose US, INC. | $74.09 | 2020-2021 | |
| Olympus America INC. | $66.85 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $65.81 | 2019 | |
| Inspire Medical Systems, INC. | $43.28 | 2024-2025 | Inspire |
| Merck Sharp & Dohme LLC | $31.46 | 2025 | Keytruda |
| Endogastric Solutions, INC | $29.68 | 2022 | |
| Kaleo, INC. | $25.57 | 2023 | Auvi-Q |
| Astrazeneca Pharmaceuticals LP | $24.31 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.37 | 2023 | Ligasure |
| Genentech USA, INC. | $14.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Viner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.